Beam Therapeutics, Inc. (BEAM)
22.85
-1.18
(-4.91%)
USD |
NASDAQ |
Nov 13, 16:00
22.99
+0.14
(+0.61%)
After-Hours: 19:59
Beam Therapeutics Market Cap : 2.364B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 2.486B |
| November 11, 2026 | 2.670B |
| November 10, 2026 | 2.602B |
| November 09, 2026 | 2.795B |
| November 06, 2026 | 2.732B |
| November 05, 2026 | 2.676B |
| November 04, 2026 | 2.875B |
| November 03, 2026 | 2.724B |
| November 02, 2026 | 2.676B |
| October 30, 2026 | 2.817B |
| October 29, 2026 | 2.978B |
| October 28, 2026 | 2.972B |
| October 27, 2026 | 2.571B |
| October 26, 2026 | 2.457B |
| October 23, 2026 | 2.484B |
| October 22, 2026 | 2.536B |
| October 21, 2026 | 2.565B |
| October 20, 2026 | 2.574B |
| October 19, 2026 | 2.498B |
| October 16, 2026 | 2.424B |
| October 15, 2026 | 2.554B |
| October 14, 2026 | 2.442B |
| October 13, 2026 | 2.523B |
| October 12, 2026 | 2.595B |
| October 09, 2026 | 2.654B |
| Date | Value |
|---|---|
| October 08, 2026 | 2.540B |
| October 07, 2026 | 2.558B |
| October 06, 2026 | 2.605B |
| October 05, 2026 | 2.651B |
| October 02, 2026 | 2.530B |
| October 01, 2026 | 2.519B |
| September 30, 2026 | 2.525B |
| September 29, 2026 | 2.532B |
| September 28, 2026 | 2.502B |
| September 25, 2026 | 2.506B |
| September 24, 2026 | 2.547B |
| September 23, 2026 | 2.517B |
| September 22, 2026 | 2.678B |
| September 21, 2026 | 2.608B |
| September 18, 2026 | 2.576B |
| September 17, 2026 | 2.548B |
| September 16, 2026 | 2.385B |
| September 15, 2026 | 2.398B |
| September 14, 2026 | 2.491B |
| September 11, 2026 | 2.477B |
| September 10, 2026 | 2.517B |
| September 09, 2026 | 2.600B |
| September 08, 2026 | 2.771B |
| September 04, 2026 | 3.063B |
| September 03, 2026 | 3.042B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Intellia Therapeutics, Inc. | 1.361B |
| Twist Bioscience Corp. | 6.992B |
| Prime Medicine, Inc. | 769.04M |
| Sarepta Therapeutics, Inc. | 1.722B |
| Q32 Bio, Inc. | 260.66M |
Market Cap Related Metrics
| PS Ratio | 16.25 |
| Price to Book Value | 2.481 |
| Price | 22.85 |
| Earnings Yield | -4.57% |